11 Things I’d Actually Look at Before Picking a GLP-1 Provider in 2026

Most people shopping for a GLP-1 telehealth provider spend too much time comparing drug names and not enough time comparing what happens after the prescription is written. The pharmacy source, the refill process, the monitoring depth, whether the price survives month two: those details matter more than the brand logo on the homepage.

Here is how I’d think through the decision, framed around the 11 factors and providers I’d genuinely consider.

1. Price Stability Past Month One

The $99 intro offer is real. Whether it holds at month three is the question you should ask before signing up.

Henry Meds runs compounded sema from roughly $179-$249 in month one, and the pricing doesn’t swing wildly after that. Fast shipping (24-72 hours), lighter clinical monitoring, cash-pay only. Good for people who just want medication without a coaching program wrapped around it.

• Best for: straightforward cash-pay access, no upsells
• Watch: monitoring is thinner than obesity-medicine-specific practices

2. Clinical Depth and Obesity-Medicine Credentials

Mochi Health is one of the few telehealth options staffed by board-certified obesity-medicine clinicians rather than general practitioners. Compounded semaglutide runs around $99/mo, tirzepatide around $199. The check-ins are more substantive than most.

• Best for: people who want actual clinical oversight, not just a prescription
• Watch: compounded meds, not FDA-approved branded drugs

3. Published Purity Testing

This one separates serious compounders from the rest. FormBlends publishes per-product lab results: HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility data. Named numbers, not vague assurances. The pharmacy is FDA-registered (503A). Semaglutide runs around $299 per vial, tirzepatide around $349, higher than some competitors on this list. FormBlends also carries a broader peptide catalog covering recovery and longevity compounds under the same clinician model, which is rare among GLP-1-only telehealth shops. Ships to 47 states.

• Best for: buyers who want verification on paper before injecting anything, or who want GLP-1s plus peptide options from one provider
• Watch: higher price point, doesn’t ship to all 50 states

4. Price-to-Access Ratio on Compounded Meds

If cash price is the primary constraint, HealthRX is worth knowing about. Compounded semaglutide from $99/mo, tirzepatide from $149/mo, free overnight shipping to all 50 states. The pharmacy is Manifest in Greer, South Carolina: a 503A/USP-797 facility with lot tracking and LegitScript certification (cert 50087439). That’s a named, verifiable source, not a generic “licensed compounding partner.”

5. Insurance and Prior-Auth Support

Ro Body has an actual prior-authorization team that works to get branded medications covered. Membership starts at $39 for the first month, then $74-$149/mo, with meds billed separately. If you have insurance that might cover Wegovy or Zepbound, the effort Ro puts into prior-auth can save thousands annually.

• Best for: people with insurance who want a real advocate in the prior-auth fight
• Watch: meds cost is a separate line item; total can be high without coverage

6. Branded Meds at the Lowest Possible Copay

Hims & Hers exited compounded GLP-1 after the Novo Nordisk settlement in March 2026 and now works with branded medications only. Injectable Wegovy runs around $299/mo, oral semaglutide around $249, Zepbound around $399. With insurance plus manufacturer savings cards, that can drop to $0-$25. The infrastructure is polished.

• Best for: people who want FDA-approved branded drugs and have good insurance
• Watch: no compounded option anymore; pricing without coverage is steep

7. New Oral GLP-1 Access

Orforglipron, Lilly’s oral GLP-1, became available via LillyDirect around April 2026 at roughly $149/mo. No injection, no mixing. Not every telehealth platform connects to LillyDirect yet, so if oral convenience matters, check before you subscribe to a platform that can’t offer it.

8. Low Monthly Overhead for the Platform Itself

PlushCare charges around $19.99/mo for membership, handles branded meds, works with insurance, and offers same-day visits. It’s not a GLP-1-only product. It’s a general telehealth platform that does GLP-1 prescriptions well. If you already use telehealth for other reasons, the marginal cost of adding weight-loss care is low.

• Best for: people who want one telehealth subscription for multiple health needs
• Watch: less specialized in obesity medicine than Mochi or Form Health

9. Maximum Coaching and Accountability

Form Health pairs an MD with a registered dietitian per patient. Program fee around $299/mo plus labs plus medication costs. The most expensive option on this list by far. But for people who’ve tried GLP-1s before and plateaued, or who have comorbidities that need real dietary guidance, the clinical team depth is genuinely different.

• Best for: high-motivation buyers with complex needs who want premium support
• Watch: total monthly cost can exceed $500 once meds and labs are added

10. Flexibility Without a Contract

MEDVi runs compounded GLP-1s from around $179 in the first month with no contracts. Eden offers compounded semaglutide at roughly $149/mo cash. Both are simple, no-lock-in options. Neither offers the monitoring depth of Mochi or the lab transparency of FormBlends, but for someone who wants to try a few months before committing, the lack of a long-term program structure is the point.

• Best for: people who want to test before committing long-term
• Watch: lighter clinical infrastructure

11. Pharmacy Verification Before Anything Else

The FDA sent warning letters to more than 30 telehealth and compounding operations in early 2026. The single most important thing anyone can do before ordering compounded GLP-1 medication is confirm the dispensing pharmacy is a named 503A facility with USP-797 compliance and independent certification. Ask specifically. If a provider won’t tell you the pharmacy name, that’s your answer.

Sesame (from about $59/mo on an annual plan, meds separate) and WeightWatchers Clinic (around $74/mo program fee plus meds) are both legitimate options worth comparing if the platforms above don’t fit, but the pharmacy verification question applies to every single one.

Prices and availability shift fast in this space. Confirm current pricing directly with any provider before subscribing, and run any GLP-1 decision past a physician who knows your full medical history.

Common Questions

Is compounded semaglutide from providers like Mochi or Henry Meds actually the same drug as Wegovy?

Not exactly. Compounded semaglutide contains the same active molecule but is mixed at a 503A pharmacy rather than manufactured by Novo Nordisk. It hasn’t gone through FDA approval as a finished product. Most reputable compounders use USP-grade API, but purity and sterility vary by pharmacy, which is why published lab results matter.

If Hims & Hers no longer offers compounded GLP-1s, what does that mean for people already on their program?

After the March 2026 Novo Nordisk settlement, Hims & Hers shifted to branded medications only. Existing patients would need to transition to Wegovy or another FDA-approved drug. Anyone currently on a compounded program through any provider should ask directly whether their pharmacy’s compounding authorization is still active under current FDA guidance.

How do I actually verify that a compounding pharmacy is legitimate before I order anything?

Ask the provider for the pharmacy’s name, state license number, and 503A registration. Cross-check the name against your state board of pharmacy’s public database. LegitScript certification, like the cert number listed for HealthRX’s Manifest pharmacy, is an additional independent check. If the provider refuses to name the pharmacy, walk away.

Does Form Health’s higher price actually produce better outcomes than a cheaper option like Eden or MEDVi?

There’s no published head-to-head data comparing these specific platforms on weight loss outcomes. What Form Health offers is more clinical contact time, an MD plus a registered dietitian per patient, and structured lab monitoring. Whether that translates to better results depends heavily on the individual. People with complex histories or previous plateaus are more likely to benefit from the added structure.

Can I switch providers mid-treatment if I find a better price or a platform I prefer?

Yes, generally. Most of these platforms are month-to-month or have short cancellation windows. The main friction is getting a new provider to continue your current dose rather than restarting titration from scratch. Bring documentation of your dose history and any prior lab work. Some providers, particularly those with their own clinical protocols, will still restart titration regardless.

Sources

• FDA warning letters to compounding firms, early 2026 (FDA.gov)
• Novo Nordisk / compounded semaglutide settlement, March 9 2026 (publicly reported)
• SURMOUNT-1 trial (tirzepatide, NEJM 2022)
• STEP 1 trial (semaglutide, NEJM 2021)
• LillyDirect orforglipron launch, April 2026 (Eli Lilly press releases)
• LegitScript certification registry (LegitScript.com)
• Individual provider pricing pages (Hims & Hers, Ro, Mochi Health, Henry Meds, PlushCare, Form Health, MEDVi, Eden, Sesame, WeightWatchers Clinic, FormBlends)